期刊文献+

拮抗剂治疗儿童哮喘的研究进展 被引量:8

Progress of Inflammatory Factor Antagonist in Treating Childhood Asthma
下载PDF
导出
摘要 哮喘患儿气道炎症形成和发展过程中,细胞因子和炎性介质起着重要的作用,随着大多数炎性介质性质被确定,炎性介质特异性的受体拮抗剂:组胺受体阻断剂、白三烯受体拮抗剂、血栓素受体拮抗剂、血小板激活因子拮抗剂、白细胞介素(IL)受体拮抗剂、抗IgE抗体治疗、神经激肽受体拮抗剂、内皮素受体拮抗剂等也被发现。受体拮抗剂的研究和应用也成为哮喘防治的热点,但如何根据不同的患者选择不同的炎性介质拮抗剂进行有效的哮喘治疗仍需更多、更深入的研究。 Inflammatory factors and cytokines play important roles in the formation and developing of airway inflammation in asthmatic children.With the definition of most of inflammatory factors,their specific receptor antagonists also have been found,which includes histamine receptor blocking pharmacon,leukotriene receptor antagonist,thromboxane receptor antagonist,platelet activating factor antagonist,interleukin receptor antagonist,anti-immunoglobulin E therapy,neurokinin receptor antagonist and endothelin receptor antagonist.The study and application of receptor antagonist have been the hot spot in the prevention and therapy of anthma.How to select different inflammatory factors antagonist according to different patients for the effective therapy for anthma still needs further and more studying.
作者 李素芬 龙苹
出处 《医学综述》 2008年第11期1713-1714,共2页 Medical Recapitulate
关键词 哮喘 炎性介质 细胞因子 拮抗剂 治疗 儿童 Asthma Inflammatory factor Cytokine Antagonist Treatment Children
  • 相关文献

参考文献19

二级参考文献78

  • 1温志红,杜华,黄小芳.甲基泼尼松龙治疗儿童中重度哮喘发作30例临床观察[J].中国全科医学,2004,7(20):1515-1516. 被引量:18
  • 2陈萍,赵海涛,孙丽,林江涛,张洪玉,黄绍光,朱宝玉,殷凯生,郑劲平,许文兵,沈华浩,李强,钟南山.全球哮喘防治创议推荐糖皮质激素的半量吸入分级治疗支气管哮喘患者的疗效分析[J].中华结核和呼吸杂志,2005,28(7):458-463. 被引量:45
  • 3沈华浩 刘富光.哮喘免疫疗法作用机制和临床应用价值研究[J].中华微生物和免疫学杂志,1998,18:35-38.
  • 4Steinshamn S, Sandsund M, Sue-Chu M, et al. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction[J]. Scand J Med Sci Sports , 2002, 12(4):211-217.
  • 5Niewoehner DE. Montelukast improved pulmonary function and asthma-specific quality of life in aspirin-intolerant asthma[J]. ACP J Club, 2002, 137(1):20.
  • 6Zhang J, Yu C, Noonan G, et al. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability[J]. Clin Ther, 2002, 24(4):574-582.
  • 7Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresportsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor ( sIL-2R), IL-4, and soluble intercellular adhesion molecule 1(sICAM-1) in children with asthma[J]. J Allergy Clin Immunol, 2002, 109(2) :257 - 263.
  • 8Dempsey O J, Kennedy G, Lipworth BJ. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukolriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma [ J ]. J Allergy Clin Immunol, 2002, 109(1):68-74.
  • 9Phipatanakul W, Nowak-Wegrzyn A, Eggleston PA, et al.The efficacy of montelukast in the treatment of cat allergen-induced asthma in children[J]. J Allergy Clin Immunol,2002, 109(5) :794 - 799.
  • 10Henderson WR Jr, Tang LO, Chu SJ, at al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model[J]. Am J Respir Crit Care Med, 2002, 165(1):108- 116.

共引文献269

同被引文献29

  • 1Bpusquet J,Jeffery P K,Busse W W,et al.Asthma.From bronchoconstriction to airways inflammation and remodeling.Am J Respir Crit Care Med,2000,161(5):1720-1745.
  • 2Lichtenstein P,Svartengren M.Genes,environments,and sex:factors of importance in atopic diseases in 7-9-year-old Swedish twins[J].Allergy,1997,52(11):1079-1086.
  • 3Harris JR,Magnus P,Samuelsen SO,et al.No evidence for effects of family environment on asthma.A retrospective study of Norwegian twins.Am J Respir Crit Care Med,1997,156(1):43-49.
  • 4Skadhauge LR,Christensen K,Kyvik KO,et al.Genetic and environmental influence on asthma:a population-based study of 11,688 Danish twin pairs[J].Eur Respir J,1999,13(1):8-14.
  • 5Koeppen-Schomerus G,Stevenson J,Plomin R.Genes and environment in asthma:a study of 4 year old twins[J].Arch Dis Child,2001,85(5):398-400.
  • 6Postma DS,Bleecker ER,Amelung PJ,et al.Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy[J].N Engl J Med,1995,333(14):894-900.
  • 7Turki J,Pak J,Green SA,et al.Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma.Evidence that Gly16 correlates with the nocturnal phenotype[J].J Clin Invest,1995,95(4):1635-1641.
  • 8Kabesch M,Schedel M,Carr D,et al.IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma[J].J Allergy Clin Immunol,2006,117(2):269-274.
  • 9Moffatt MF,Kabesch M,Liang L,et al.Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma[J].Nature,2007,448(7152):470-473.
  • 10Tavendale R,Macgregor DF,Mukhopadhyay S,et al.A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications[J].J Allergy Clin Immunol,2008,121(4):860-863.

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部